Tuesday, May 16, 2023

Chemists unravel reaction mechanism for clean energy catalyst

Pulse radiolysis experiments at Brookhaven Lab revealed rapid reactivity that has never been observed before

Peer-Reviewed Publication

DOE/BROOKHAVEN NATIONAL LABORATOry

Pulse Radiolysis Lab 

IMAGE: DMITRY POLYANSKY (LEFT) AND DAVID GRILLS IN THE PULSE RADIOLYSIS LAB WHERE THE RESEARCH WAS CONDUCTED. HERE, GRILLS PROGRAMS A SYRINGE PUMP THAT DELIVERS THE CATALYST TO THE RADIOLYSIS CELL. POLYANSKY ADJUSTS THE RADIOLYSIS CELL INSIDE A WHITE INSULATED COMPARTMENT. view more 

CREDIT: BROOKHAVEN NATIONAL LABORATORY

UPTON, NY—Hydrogen, the simplest element on Earth, is a clean fuel that could revolutionize the energy industry. Accessing hydrogen, however, is not a simple or clean process at all. Pure hydrogen is extremely rare in nature, and practical methods to produce it currently rely on fossil fuels. But if scientists find the right chemical catalyst, one that can split the hydrogen and oxygen in water molecules apart, pure hydrogen could be produced from renewable energy sources such as solar power.

Now, scientists are one step closer to finding that catalyst. Chemists at the University of Kansas and the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory have unraveled the entire reaction mechanism for a key class of water-splitting catalysts. Their work was published today in Proceedings of the National Academy of Sciences (PNAS).

“It’s very rare that you can get a complete understanding of a full catalytic cycle,” said Brookhaven chemist Dmitry Polyansky, a co-author of the paper. “These reactions go through many steps, some of which are very fast and cannot be easily observed.”

Rapid intermediate steps make it difficult for scientists to decipher exactly where, when, and how the most important parts of a catalytic reaction occur—and therefore, if the catalyst is suitable for large-scale applications.

At the University of Kansas, associate professor James Blakemore was researching possible candidates when he noticed something unusual about one catalyst in particular. This catalyst, called a pentamethylcyclopentadienyl rhodium complex, or Cp*Rh complex, was demonstrating reactivity in an area where molecules are usually stable.

“Metal complexes—molecules that contain a metal center surrounded by an organic scaffold—are important for their ability to catalyze otherwise difficult reactions,” said Blakemore, who is also a co-author of the paper. “Typically, reactivity happens directly at the metal center, but in our system of interest, the ligand scaffold appeared to directly take part in the chemistry.”

So, what exactly was reacting with the ligand? Was the team really observing an active step in the reaction mechanism or just an undesirable side reaction? How stable were the intermediate products that were produced? To answer questions like these, Blakemore collaborated with chemists at Brookhaven Lab to use a specialized research technique called pulse radiolysis.

Pulse radiolysis harnesses the power of particle accelerators to isolate rapid, hard-to-observe steps within a catalytic cycle. Brookhaven’s Accelerator Center for Energy Research (ACER) is one of only two locations in the United States where this technique can be conducted, thanks to the Lab’s advanced particle accelerator complex.

“We accelerate electrons, which carry significant energy, to very high velocities,” said Brookhaven chemist David Grills, another co-author of the paper. “When these electrons pass through the chemical solution we’re studying, they ionize the solvent molecules, generating charged species that are intercepted by the catalyst molecules, which rapidly alter in structure. We then use time-resolved spectroscopy tools to monitor the chemical reactivity after this rapid change occurs.”

Spectroscopic studies provide spectral data, which can be thought of as the fingerprints of a molecule’s structure. By comparing these signatures to known structures, scientists can decipher physical and electronic changes within the short-lived intermediate products of catalytic reactions.

“Pulse radiolysis allows us to single out one step and look at it on a very short timescale,” Polyansky said. “The instrumentation we used can resolve events at one millionth to one billionth of a second.”

By combining pulse radiolysis and time-resolved spectroscopy with more common electrochemistry and stopped-flow techniques, the team was able to decipher every step of the complex catalytic cycle, including the details of the unusual reactivity occurring at the ligand scaffold.

“One of the most remarkable features of this catalytic cycle was direct involvement of the ligands,” Grills said. “Often, this area of the molecule is just a spectator, but we observed reactivity within the ligands that had not yet been proven for this class of compounds. We were able to show that a hydride group, an intermediate product of the reaction, jumped onto the Cp* ligand. This proved that the Cp* ligand was an active part of the reaction mechanism.”

Capturing these precise chemical details will make it significantly easier for scientists to design more efficient, stable, and cost-effective catalysts for producing pure hydrogen.

The researchers also hope their findings will provide clues for deciphering reaction mechanisms for other classes of catalysts.

“In chemistry, findings like ours can often be generalized and applied to optimize other systems, but obtaining critical details on rapid reactivity, like we have done here, is a key step,” Blakemore said. “We hope other research groups will take our insights and build on them, perhaps by using ligand-promoted reactivity to build better catalysts.”

This study is just one set of experiments among a large body of clean energy work that scientists at the University of Kansas and Brookhaven Lab are conducting.

“We’re building the fundamental chemical knowledge that will, one day, help scientists design the optimal catalyst for producing pure hydrogen,” Polyansky said.

This work was supported by the National Science Foundation and the DOE Office of Science.

Brookhaven National Laboratory is supported by the Office of Science of the U.S. Department of Energy. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit science.energy.gov.

Follow @BrookhavenLab on Twitter or find us on Facebook.

Gatekeepers of Extermination: SS Camp Physicians and Their Scope of Action

Author, Article, and Disclosure Information

Abstract

The role of camp physicians of the Waffen-SS (“Armed SS,” military branch of the Nazi Party’s Schutzstaffel) in the implementation of the Holocaust has been the subject of limited research, even though they occupied a key position in the extermination process. From 1943 and 1944 onward, SS camp physicians made the individual medical decisions on whether each prisoner was fit for work or was immediately subjected to extermination, not only at the Auschwitz labor and extermination camp but also in pure labor camps like Buchenwald and Dachau. This was due to a functional change in the concentration camp system during World War II, where the selection of prisoners, which had previously been carried out by nonmedical SS camp staff, became a main task of the medical camp staff. The initiative to transfer sole responsibility for the selections came from the physicians themselves and was influenced by structural racism, sociobiologically oriented medical expertise, and pure economic rationality. It can be seen as a further radicalization of the decision making practiced until then in the murder of the sick. However, there was a far-reaching scope of action within the hierarchical structures of the Waffen-SS medical service on both the macro and micro levels. But what can this teach us for medical practice today? The historical experience of the Holocaust and Nazi medicine can provide a moral compass for physicians to be sensitive to the potential for abuse of power and ethical dilemmas inherent in medicine. Thus, the lessons from the Holocaust could be a starting point for reflecting on the value of human life in the modern economized and highly hierarchical medical sector.


Gatekeepers of Extermination: SS Camp Physicians and Their Scope of Action
Nico Biermanns, MEd
History of Medicine
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0362

Huneke wins grant to research lesbians in the Third Reich


Grant and Award Announcement

GEORGE MASON UNIVERSITY

Samuel Clowes Huneke, Assistant Professor, History and Art History, has been awarded a Sharon Abramson Research Grant from the Holocaust Educational Foundation of Northwestern University. The award will enable him to complete research for his forthcoming book on lesbians in Nazi Germany. 

For many decades after the end of World War II, the fates of queer women were ignored. Because female homosexuality had not been criminalized explicitly, historians long argued that lesbians were not persecuted by the Nazi regime.  

In contrast, Huneke’s book, which is under advanced contract with Aevo-University of Toronto Press, argues that queer women under Nazism faced forms of persecution shaped by misogyny as well as anti-gay animus. The book further contends that in spite of this persecution, queer women sought to carve out spaces of community and tolerance for themselves and that their tenacity in the face of fascism can serve as a model for queer politics in our own time. 

The Holocaust Educational Foundation of Northwestern University awards Sharon Abramson Research Grants annually to support research related to the Holocaust. 

###

About George Mason University

George Mason University is Virginia's largest public research university. Located near Washington, D.C., Mason enrolls 38,000 students from 130 countries and all 50 states. Mason has grown rapidly over the last half-century and is recognized for its innovation and entrepreneurship, remarkable diversity and commitment to accessibility. Learn more at http://www.gmu.edu.

\

Unique insights into COVID-19 impact on human experience


New book provides insightful perspective on COVID-19 impact on human experience


Book Announcement

BENTHAM SCIENCE PUBLISHERS

Bentham Science’s latest book on COVID-19, COVID-19: Origin, Impact and Management, is now published, offering a comprehensive summary of recent findings on the impact of COVID-19 on various aspects of human life. The book is edited by expert scientists, and features contributions from academicians and scholars from leading institutions in India. It provides readers from science, humanities and commerce backgrounds with a valuable and interdisciplinary perspective on the pandemic.

With a focus on findings from India, the book covers a range of topics including the effects of COVID-19 on physical and psychological well-being, loss of jobs, pay cuts, education, and unpaid caregiving. The book also blends basic and applied research in biology, medicine and social science to offer readers a comprehensive view of the effects of the outbreak.

The book's key features include updated references for advanced readers, and interdisciplinary content making it useful for researchers and working professionals in industry and academia. Its blend of basic and advanced research provides general readers with a broad and insightful perspective on COVID-19's impact on the human experience.

The first part of this book includes interesting topics such as a review on organophosphates and SARS-CoV-2 in connection with severe respiratory disease, the moderating effect of government stimulus programs, psychological distress and COVID-19, the diversified impact of COVID-19 on the development of children, and more.

COVID-19 has affected the lives of people across the globe, and this book offers a valuable resource for those seeking to understand the pandemic's impact. The book is expected to be a valuable addition to the literature on COVID-19 and its effects on human life.

To learn more about COVID-19 and its impact on various aspects of human life, please visit the site.


Experts say it’s not yet time to take off masks in the health care setting

Embargoed News from Annals of Internal Medicine

Peer-Reviewed Publication

AMERICAN COLLEGE OF PHYSICIANS

1. Experts say it’s not yet time to take off masks in the health care setting
Abstract: https://www.acpjournals.org/doi/10.7326/M23-1190
URL goes live when the embargo lifts


A new commentary from infectious disease experts at George Washington University School of Medicine and the National Institutes of Health (NIH) says for patient safety, masking should continue in health care settings. This message conflicts with a recent commentary from authors from 8 U.S. institutions suggesting that the time for universal masking is over. The commentary is published in Annals of Internal Medicine.

Masking has been a controversial mitigation strategy during the COVID-19 pandemic because high-quality evidence of efficacy is lacking and because the topic has become highly politicized. Regardless, real-world experience demonstrates the effectiveness of mask-wearing in clinical settings where data shows that transmission from patient-to-staff and staff-to-patent, when both are masked, is uncommon. Since health care personnel report being driven to show up for work even when they are ill themselves, the argument in support of mask-wearing becomes even more compelling.

Those without symptoms may also transmit respiratory viruses, particularly SARS-CoV-2. While the Omicron strain has been milder, infection could still cause severe or life-threatening disease or prolonged illness if transmitted to at-risk patients, such as the elderly or immunocompromised. With the still-looming risks, now does not seem the time to take off masks in the health care setting. Instead, the authors advocate strongly for continued mask use for infection prevention.

Media contacts: For an embargoed PDF, please contact Angela Collom at acollom@acponline.org. To speak with corresponding author David K. Henderson, MD, please email dhenderson@cc.nih.gov.
 ----------------------------

2. Updated evidence suggests masks may reduce risk for SARS-CoV-2 infection in community and health care settings
A beneficial effect of N95 respirators in health care settings could not be ruled out
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0570
Editorial: https://www.acpjournals.org/doi/10.7326/M23-1120
URL goes live when the embargo lifts
The final and major update to a rapid, living review of published evidence suggests that masks may be associated with a small reduction in risk for COVID-19 infection in community settings versus no mask use and both surgical masks and N95 respirators may be associated with similar infection risk in routine patient care settings. However, a beneficial effect of N95 respirators could not be ruled out in the health care setting. The review is published in Annals of Internal Medicine.

In June 2020, Annals published an initial living review of research on mask use which found insufficient evidence to determine effects of masks on COVID-19 infection. The initial review was followed by eight brief updates that found low to moderate strength evidence for an association between mask use and decreased risk for SARS-CoV-2 infection in community settings, but evidence on N95 versus surgical masks in health care settings and risk for COVID-19 infection remained insufficient. This 9th and final review is different because it includes enough evidence to be considered a major update.

Investigators from Oregon Health & Science University reviewed three randomized trials and 21 observational studies to update an evidence synthesis on N95, surgical, and cloth mask effectiveness in community and health care settings for preventing SARS-CoV-2 infection. The authors found that mask use may be associated with a small, reduced risk for COVID-19 infection versus no mask use in community settings. However, they note that that the interventions, settings, and populations included in the reviewed studies varied and adherence was suboptimal, which may have impacted outcomes. The authors note that trial and observational studies of surgical or N95 mask use compared with no mask were imprecise or limited, with evidence on other mask comparisons in health care settings remaining insufficient.

An accompanying editorial by Annals Editor-in-Chief Christine Laine, MD, MPH and Deputy Editor Stephanie Chang, MD, MPH provides important context for understanding why recent evidence reviews do not provide a definitive answer about the benefits of masking. Studies vary widely in what they are designed to determine, such as the effectiveness of masks at preventing viral penetration or the effectiveness of masking recommendations. Because these studies are conducted in the real world where infection risk-reduction strategies also vary, it may be difficult to determine the effectiveness of a single component of that strategy. And finally, the authors say we must be explicit in weighing benefits and harms. While some may consider any evidence of benefit sufficient to justify masking, others believe that inconvenience, discomfort, or communication impedance outweigh small benefits. To get to the truth about masking, the authors say it is imperative to design studies that fill information gaps, interpret the evidence accurately, and are honest about what we do and do not know.

Media contacts: For an embargoed PDF, please contact Angela Collom at acollom@acponline.org. To speak with corresponding author Roger Chou, MD, please contact Erik Robertson at robineri@ohsu.edu.
----------------------------
3. Adding a single data point to COVID-19 reporting may more accurately convey the real-time burden of infection in health care settings
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0618
URL goes live when the embargo lifts
In a new ‘Medicine and Public Issues,’ authors from Tufts Medical Center, Veterans Affairs Boston Healthcare System, Harvard Medical School and the Massachusetts Department of Public Health advocate for the inclusion of both the total number of COVID-19 hospitalizations daily and the number of inpatients who received dexamethasone at any point during their hospital stay. The authors emphasize that the addition of this data element is an easy and much-needed update to COVID-19 surveillance efforts that may help to more accurately convey the real-time burden of a rapidly changing infection in health care settings. The article is published in Annals of Internal Medicine.

On 10 January 2022, the Massachusetts Department of Public Health (MDPH) began requiring hospitals to expand surveillance to include reports of both the total number of COVID-19 hospitalizations daily and the number of inpatients who received dexamethasone at any point during their hospital stay. This requirement was added because dexamethasone administration had been shown to be highly correlated with disease severity and was sensitive to the changing epidemiology of new immune-evasive COVID-19 variants.

The authors highlight that the purpose of the ongoing requirement by the MDPH to report dexamethasone is not to minimize pandemic impacts, but to instead understand the ongoing burden of the pandemic in the setting of a changing landscape of population immunity and viral variants. The authors point to COVID-19 data collected from all 68 acute care hospitals in Massachusetts between January 2022 and January 2023, which show that the proportion of persons hospitalized for COVID-19 who received dexamethasone decreased from 49.6 to 33 percent. According to the authors, these data have been used to communicate risk and weigh community-level recommendations by health authorities. They also emphasize that their experience highlights the importance of ongoing review and reevaluation to maintain the utility and predictive value of public health surveillance definitions.

Media contacts: For an embargoed PDF, please contact Angela Collom at acollom@acponline.org. To speak with corresponding author Shira Doron, MD, MS, please email Jeremy Lechan at jlechan@tuftsmedicalcenter.org.

----------------------------